Mikart

As the pharmaceutical industry evolves, the exploration of alternative and plant-derived therapies has moved from the fringe to the forefront of innovation. Cannabinoids and psilocybin—once primarily associated with natural wellness communities—are now the focus of serious research and emerging regulatory pathways aimed at treating a wide range of conditions, including chronic pain, epilepsy, anxiety, depression, and PTSD. At Mikart, we recognize the potential of these therapies and are well-positioned to support companies seeking to bring them to market....

Navigating Emerging Therapeutics: How Mikart Supports Cannabinoid and Psilocybin Drug Development – Mikart As the pharmaceutical industry evolves, the exploration of alternative and plant-derived therapies has moved from the fringe to the forefront...

Liquid-oral formulations, from solutions to syrups, come with their fair share of complexities. Think solubility woes, stability concerns, and taste challenges. But fear not, for where there's a will, there's a way, especially when you've got Mikart, a dynamic Contract Development and Manufacturing Organization (CDMO) in your corner. Why partner up? For starters, Mikart brings a boatload of expertise to the table....

Sailing Smoothly: Partnering with a CDMO for Liquid-Oral Formulation Development – Mikart Liquid-oral formulations, from solutions to syrups, come with their fair share of complexities. Think solubility woes, stability concerns, and taste...

Mikart commemorates Juneteenth, a celebration of freedom and equality! Today let's reflect, learn, and strive for a future where all embrace equality, justice, and freedom.

The Unapproved Drugs Initiative (UDI) is a program launched by the Food and Drug Administration (FDA) in 2006 to remove unapproved drugs from the market and ensure that all drugs meet modern standards of safety, effectiveness, quality, and labeling. Unapproved drugs are those that have not been evaluated by the FDA for safety and effectiveness, but are still marketed and sold in the United States....

Unapproved Drugs Initiative – Mikart The Unapproved Drugs Initiative (UDI) is a program launched by the Food and Drug Administration (FDA) in 2006 to remove...